phenylalanine and Abdominal Obesity

phenylalanine has been researched along with Abdominal Obesity in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adamsen, D; Beckers, J; Blau, N; Crabtree, M; Fuchs, H; Gailus-Durner, V; Homma, D; Horsch, M; Hrabě de Angelis, M; Ichinose, H; Klingenspor, M; Konrad, D; Korner, G; Ledermann, B; Rassi, A; Rathkolb, B; Rebuffat, A; Rozman, J; Scavelli, R; Scherer, T; Thöny, B; Wolf, E; Wolfrum, C	1
Califf, RM; Giles, T; Haffner, SM; Hernandez, AF; Krum, H; Leiter, LA; Martinez, FA; Mazzone, T; McMurray, JJ; Rutten, GE; Standl, E; Sun, JL; Thomas, L; Tognoni, G; Wong, YW	1

Trials

1 trial(s) available for phenylalanine and Abdominal Obesity

Article	Year
Predictors of incident heart failure hospitalizations among patients with impaired glucose tolerance: insight from the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research study. Circulation. Heart failure, 2013, Volume: 6, Issue:2 Topics: Adiposity; Aged; Albuminuria; Biomarkers; Blood Glucose; Creatinine; Cyclohexanes; Double-Blind Method; Female; Glucose Metabolism Disorders; Heart Failure; Hospitalization; Humans; Hypoglycemic Agents; Incidence; Linear Models; Male; Middle Aged; Multivariate Analysis; Nateglinide; Nonlinear Dynamics; Obesity, Abdominal; Phenylalanine; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Tetrazoles; Time Factors; Treatment Outcome; Valine; Valsartan; Waist Circumference	2013

Article

Year

Predictors of incident heart failure hospitalizations among patients with impaired glucose tolerance: insight from the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research study.

Circulation. Heart failure, 2013, Volume: 6, Issue:2

Topics: Adiposity; Aged; Albuminuria; Biomarkers; Blood Glucose; Creatinine; Cyclohexanes; Double-Blind Method; Female; Glucose Metabolism Disorders; Heart Failure; Hospitalization; Humans; Hypoglycemic Agents; Incidence; Linear Models; Male; Middle Aged; Multivariate Analysis; Nateglinide; Nonlinear Dynamics; Obesity, Abdominal; Phenylalanine; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Tetrazoles; Time Factors; Treatment Outcome; Valine; Valsartan; Waist Circumference

2013

Other Studies

1 other study(ies) available for phenylalanine and Abdominal Obesity

Article	Year
Mildly compromised tetrahydrobiopterin cofactor biosynthesis due to Pts variants leads to unusual body fat distribution and abdominal obesity in mice. Journal of inherited metabolic disease, 2016, Volume: 39, Issue:2 Topics: Adipose Tissue; Alleles; Animals; Biopterins; Body Fat Distribution; Body Weight; Cholesterol; Female; Genotype; Glucose; Heterozygote; Homozygote; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mutation; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Obesity, Abdominal; Phenylalanine; Phosphorus-Oxygen Lyases; Transcriptome	2016

Article

Year

Mildly compromised tetrahydrobiopterin cofactor biosynthesis due to Pts variants leads to unusual body fat distribution and abdominal obesity in mice.

Journal of inherited metabolic disease, 2016, Volume: 39, Issue:2

Topics: Adipose Tissue; Alleles; Animals; Biopterins; Body Fat Distribution; Body Weight; Cholesterol; Female; Genotype; Glucose; Heterozygote; Homozygote; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mutation; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Obesity, Abdominal; Phenylalanine; Phosphorus-Oxygen Lyases; Transcriptome

2016